This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Pharmacology 2017

The British Pharmacological Society's flagship annual meeting attracts over 1,000 scientists each year from across the world.

11–13 Dec 2017

Abstracts deadline: 16 Nov 2017

Registration deadline: 01 Dec 2017

Queen Elizabeth II Conference Centre, London, UK - View map

  • Overview
  • Registration
  • Programme
  • Day 1
  • Day 2
  • Day 3
  • Abstracts & Bursaries
  • Accommodation
  • Venue & Travel
  • Sponsorship & Exhibitions

The British Pharmacological Society is keen that Pharmacology 2017 builds on the memorable and engaging experiences that members have enjoyed at our flagship annual meetings in recent years.

With this in mind, we are pleased to announce that the dates for the meeting have changed to Monday 11 – Wednesday 13 December 2017 and we will remain at the Queen Elizabeth II Conference Centre, London.

The Society's original reservation for this venue was to have been later in December due to limited availability, but we have worked hard to secure our preferred dates. We hope that this news will enable maximum participation in the meeting: many members, as well as exhibitors and key partners, had already let us know that an earlier date in December would be an improvement.

We are delighted to host Pharmacology 2017 in association with a guest society:

Pharmacology 2017 supporters


Online registration is now closed.  Please note that we will be able to take delegate registration onsite however the below onsite registration fees will apply. For any questions please contact

Social events

Monday 11 December 2017

A networking reception, open to all attendees, will be held in the evening on the first day.
Venue: Queen Elizabeth II Conference Centre

Tuesday 12 December 2017

The Annual Dinner and Prize Giving, is open to all attendees, will be held in the evening on the second day. The event will start with a networking drinks reception, followed by a 3-course meal and the prize giving ceremony.
Venue: One Whitehall Place, 2 Whitehall Court London SW1A 2EJ

Please note that tickets for the Annual Dinner and Prize Giving have now sold out. 

Need help with registration?

If you require any assistance or have any questions regarding your registration for Pharmacology 2017, please contact the Meetings Team or telephone +44 (0)20 7843 0492).


Registration fees

British Pharmacological Society Members Registration charges until Friday 1 December 2017 Onsite Registration Fees
Day registration complimentary £50
Full registration (3 days) complimentary £50
Student day registration complimentary £50
Student day registration (3 days) complimentary £50
Affiliate Non-Member rate (Biochemical Society, Japanese Pharmacological Society, British Society for Cardiovascular Research. EPHAR members)
Day registration £65 £115
Full registration (3 days) £170 £220
Non-Member rate
Day registration £125 £175
Full registration (3 days) £295 £345
Student day registration £65 £115
Student day registration (3 days) £170 £220
Welcome Reception organised by the Young Pharmacologists
Student Ticket £20 -
Non-Student Ticket £25 -
BPS Annual Dinner and Prize Giving
Ticket £55 -


We were delighted to confirm the following symposia for Pharmacology 2017:
Download the programme at a glance.

Sessions at Pharmacology 2017:

Cardiovascular and Respiratory Pharmacology

  • Cardiovascular pleiotropy, fact or fantasy?
  • Clearing the blockage: bench to bedside approaches for clearing inflammation-induced thrombosis
  • Immune targets in hypertension


  • A new look at imidazolines, their receptors and emerging therapeutic applications
  • Pharmacological strategies for disease modification in the treatment of neurodegenerative proteinopathies
  • Sigma-1 receptors as therapeutic targets

Integrated Systems Pharmacology 

  • Inflammation and immunity; new drug discovery opportunities
  • New uses for 21st Century anti-histamines
  • Cytokine-based therapies in inflammatory diseases

Molecular and Cellular Pharmacology

  • When less is more; rational drug design through fragment based drug discovery
  • Membrane trafficking – the highway to novel pharmacological targets
  • Protein-Protein interactions: from biochemistry to drug discovery and pharmacology

Toxicology & Drug Discovery, Development and Evaluation

  • Pharmacological modulation of gene expression - The therapeutic potential of epigenetic medicines
  • Therapeutics research in vulnerable populations: expanding our frontiers
  • Advances in drug development and regulation, MHRA


  • Engaging with ethical review: strengthening relationships between ethical review bodies and researchers
  • Mind the gap: clinical pharmacology in the NHS and pharmaceutical industry
  • Innovations in pharmacology education
  • Creating & fostering a diverse professional network
If you have any queries or need further information, please contact the Meetings Team ( or +44 (0)20 7843 0492).
Download the 'Programme at a glance'.
Download the 'Symposium summary - Day 1'.
Download the ‘Day 1 overview’.
Download Day 1 oral presentations
Download Day 1 poster presentations

Bootcamp: Opportunities for young pharmacologists in industry in the UK and internationally


Are you curious about the career opportunities available to pharmacologists in industry in the UK and internationally? You are invited to this session organised by the Society’s industry sub-committee, offering a unique insight into more established pharmacologists’ career paths in industry, and their experiences recruiting to roles across pharmacology. Participants are encouraged to bring along any questions or concerns to talk through with the panel for what should prove to be a lively Q&A discussion session.


  • Malcolm Skingle, GSK, UK

  • Gillian Burgess, Vertex Pharmaceuticals, UK

  • Janet Nicholson, Boehringer Ingelheim, UK

  • Helen Tomkinson, AstraZeneca, UK

  • Massimiliano (Max) Bianchi, Transpharmation Ireland, UK

Symposia summaries:

Track 1: Cardiovascular pleiotropy, fact or fantasy?
This session should be of interest to those interested in “non-cardiovascular” drugs that unexpectedly confer beneficial cardiovascular effects, and in particular on therapies for patients with Type 2 diabetes, a population at significant risk of cardiovascular morbidity and mortality. The advent of new pharmacological agents that show potential above that of their primary target is an exciting prospect. This symposium session on the topic of cardiovascular pleiotropy is the fifth presented at BPS in collaboration with the British Society for Cardiovascular Research (BSCR).

Track 2: A new look at imidazolines, their receptors and emerging therapeutic applications
To increase awareness of recent research in an important, yet neglected, field in pharmacology and to highlight functional links between the pharmacology of imidazolines and other well established neurotransmitter systems, especially monoamines.

Track 3: Inflammation and immunity; new drug discovery opportunities
To increase awareness of a broad range of activities that have been developed to deepen our understanding of inflammation and promote industry-academic drug discovery.

Track 4: When less is more; rational drug design through fragment based drug discovery
We will address the current status of fragment-based drug discovery (FBDD), its future and its impact on the generation of new medicines. Specifically, we will discuss how a careful structure guided assembly of compounds can lead to drugs with suitable physicochemical properties that bind with high affinity and specificity to their intended targets. The initial characterisation of weakly binding fragments can be problematic. The main limitations being the methods of screening, whether the target can be prepared in a suitable form and whether the fragments are sufficiently soluble. We will discuss the methods that have contributed to the general productivity in this area with real life examples including the adenosine A2a and mGlu5 receptors. Learnings from FBDD can be applied to conventional HTS hits with molecules being stripped back to key elements and then ‘regrown’ into clinical candidates. Kinetics has a key role to play in this process of optimisation as compound affinities and we will outline the methods that will provide this information in the very early stages of this FBDD process. Lead compound generation itself requires commitment as the process can be long so confidence in the target and the fragment hits needs to be high. In contrast the initial investment can be relatively small and the implementation and development of FBDD techniques is often best refined in an environment with a focus that comes from working within small companies and academic groups.

Track 5: Pharmacological modulation of gene expression - the therapeutic potential of epigenetic medicines
To highlight advances in our understanding of small molecule epigenetic inhibitors. Selected speakers will illustrate the dramatic progress been seen across a range of therapeutic areas. The talks will help raise awareness of the latest targets, molecules and exciting pre-clinical data.

Track 6: Engaging with ethical review: strengthening relationships between ethical review bodies and researchers
To provide scientists with information on the range of tasks carried out by local ERBs that operate according to good practice, to raise awareness of the full context and range of their functions and aims. To provide guidance on effective communication and interaction between researchers and their ERBs, animal technologists, veterinarians and Three Rs groups, so that the entire process of local ethical review works effectively with maximum benefits for all concerned – and both science and welfare are optimised. This workshop is a CPD opportunity for personal and project licence holders (CPD is a requirement for all ‘named’ persons under UK legislation).



Download the 'Programme at a glance'.
Download the 'Symposium summary - Day 2'.
Download the ‘Day 2 overview’.
Download Day 2 oral presentations  
Download Day 2 poster presentations  

Bootcamp: Understanding the publishing process. An opportunity to share experiences around publishing research, including advice and tips from the BPS journals Editors-in-Chief on best practice, how to submit, handling reviewer feedback, and meeting journal and funder requirements


Are you interested in learning more about how to get published in an academic journal? Would you like to discuss your experiences of publishing work in an informal and interactive way? The BPS journal’s Editors-in-Chief are hosting a careers bootcamp on Tuesday 12th December from 8am-9am. The session will be a chance to meet the Editors-in-Chief of the British Journal of Pharmacology, British Journal of Clinical Pharmacology, and Pharmacology Research & Perspectives to gain insight and tips on journals publishing best practice. The session will be in a Q&A style format and attendees are encouraged to bring examples of their own experiences for discussion, questions for the Editors, and ideas for how journals can help to make the publishing process more transparent and approachable.


  • Amrita Ahluwalia, Queen Mary University of London, UK

  • Adam Cohen, Centre for Human Drug Research, Netherlands

  • Darrell Abernethy, Food and Drug Administration, USA

  • Andrew Lawrence, Howard Florey Institute, Australia

Hot trends in pharmacology: new science and the business landscape

Three leading industry experts will provide their perspectives and share sector insights: Giovanni Mariggi PhD, a Principal at Medicxi, a life sciences-focused investment firm with a main focus on growth stage clinical opportunities; Catherine Beech MD, OBE, an entrepreneur and executive director for early stage and start-up life science companies with angel funding and venture capital expertise; and Mene Pangalos PhD, Executive Vice-President of AstraZeneca’s Innovative Medicines and Early Development Biotech Unit, an internationally renowned expert in neuroscience and drug discovery who has overall responsibility for pharmaceutical discovery research and early development activities.


  • Professor David Webb, President, British Pharmacological Society, UK
  • Dr Tom Blackburn, President Emeritus & Chair, Industry Sub-Committee, UK
  • Dr Mene N Pangalos, AstraZeneca, UK
  • Dr Catherine Beech, Exonate, UK
  • Dr Giovanni Mariggi, Medicxi, UK

Symposia summaries:

Track 1: Clearing the blockage: bench to bedside approaches for clearing inflammation-induced thrombosis
The objective of the symposium is to bring together scientists and clinicians of all levels to discuss the diverse nature of thrombosis and potential therapeutic strategies to treat this disease area.

Track 2: Pharmacological strategies for disease modification in the treatment of neurodegenerative proteinopathies
To draw attention to the diverse pharmacology underlying efforts to develop disease modifying therapies for neurodegenerative proteinopathies. Presentations are intended to cross disciplines and provide perspectives from neuropathology, neuropharmacology, neurology, and biomarker research, raising awareness of the latest discoveries, theories and results from experts driving research in this area.

Track 3: New uses for 21st Century anti-histamines
Histamine is the most pleiotropic of chemicals in the human body. The classic 20th century antihistamines (H1 and H2 receptors) are one of the most successful clinical drug classes ever. This symposium will explore some key examples of new uses for targeting the 21st century H3 and H4 histamine receptors, from preclinical pharmaco-validation (pain and diabetic complications), through Phase I and II clinical developments (atopic dermatitis, vestibular disorders) to successful drug registration (narcolepsy). The international array of speakers (combination of academic, pharmaceutical and company experts) will discuss issues arising from the pharmacological rationale and the challenging developmental process for these new drug classes of anti-histamines which are now beginning to show significant promise.

Track 4: Membrane trafficking – the highway to novel pharmacological targets
Trafficking of receptors is often overlooked in identification of potential drug targets, with many aspects of trafficking biology up for contention. Utilisation of this mechanism in treatment of disease will rely on interdisciplinary relationships between pharmacologists, physiologists, drug developers and, ultimately, clinicians. This symposium would agglomerate researchers and opinion leader in this field from around the world and act as a platform for discussion and collaboration. Membrane trafficking represents a research gap, and as we represent the Young Pharmacologists Advisory Group of the British Pharmacological Society, we hope this will not only provide an educational experience for young scientists, but also encourage research into this field and promote international collaboration with multi-disciplinary collaborators to pave the future for drug discovery.

Track 5: Therapeutics research in vulnerable populations: expanding our frontiers
Educate and inform attendees about the design and delivery of all stages of pharmacology research from early phase clinical trials to RCTs in vulnerable populations.

Track 6: Mind the gap: clinical pharmacology in the NHS and pharmaceutical industry
• Outline clinical pharmacology and the industrial strategy
• CPT in the NHS, challenges and opportunities
• Raising the visibility of clinical pharmacology
• How can we develop clear career pathways and provide the right training and opportunities?
• What clinical pharmacology skills does industry really need, and how can we support it?
• How can clinical pharmacologists work best with other healthcare professionals?



Download the 'Programme at a glance'.
Download the 'Symposium summary - Day 3'.
Download the ‘Day 3 overview’.
Download Day 3 oral presentations  
Download Day 3 poster presentations  

Bootcamp: Education


Following the success of last year’s bootcamp, the Education and Training Committee in partnership with the Education & Skills affinity group will run a panel-style discussion session for delegates on 13th December 8-9 am. This session is designed to be informative and interactive with an aim to highlight and promote key Society education projects and listen to the views and needs of members. We invite you to join us for some bite-size talks – and a lively discussion about the future of education at the Society.


  • Melisa Wallace, Swansea University Medical School, UK

  • Dave Lewis, University of Leeds, UK

  • Michael Seed, University of East London, UK

  • Steven Tucker, Aberdeen University, UK

Symposia summaries:

Track 1: Immune targets in hypertension
This symposium will raise the awareness of the known roles of immune cells in driving chronic vascular disease and will provide a state-of-the-art update on this new and fast developing area of research.

Track 2: Sigma-1 receptors as therapeutic targets
The number of therapeutic uses for sigma-1 receptor ligands crosses many disciplines. These include, but are not limited to depression, cancer, Alzheimer's, Parkinson's, neuropathic pain. The profile of the sigma-1 receptor however, means that few researchers in each field are aware of the progress being made and the potential of sigma-1 receptor ligands in their particular field. This symposium will bring together researchers in a variety of fields working on the same target, allowing cross fertilization between disciplines. In addition, the presence of this symposium at Pharmacology 2017 will raise the profile of the sigma-1 receptor among those unaware of its existence and importance. Despite its low profile, several clinical trials are underway utilizing sigma-1 receptor ligands for conditions affecting a large percentage of the population.

Track 3: Cytokine-based therapies in inflammatory diseases
Immunoinflammatory responses play a key role in all the main chronic pathologies leading causes of death and morbidity including cancer, allergies, autoimmune and metabolic diseases. A better integration between all researchers and clinicians working in the fields of pharmacology, immunology and drug discovery would be strongly required for improving the study, development and rational use of immune specific therapies. The aim of this symposium is to summarise our current understanding of cytokine-targeted therapies in inflammatory diseases. To achieve this goal we have invited a number of leading national and international clinical and basic scientists with an international track record and who are considered prominent researchers in their area.

Track 4: Protein-Protein interactions: from biochemistry to drug discovery and pharmacology
Provide an overview of the biochemistry, pharmacology and cell biology of PPIs with particular emphasis on their targeting and the importance of PPI inhibitors as therapeutics and powerful biological tool compounds.

Track 5: Advances in drug development and regulation, MHRA
To provide members of the British Pharmacological Society with information about advances in development strategies and regulation as well as new approaches in clinical trials and pharmacovigilance. Attendees will be able to meet and network with MHRA members and discuss regulation and change in Q&A sessions after each presentation. The symposium will allow MHRA to reach key stakeholder groups and communicate changes in regulation and updates in drug development. The MHRA are responsible for helping educate the public and healthcare professionals on the risks and benefits of medicines, medical devices and blood components, leading to safer and more effective use. MHRA supports innovation, research and development that’s beneficial to public health.

Track 6: Innovations in pharmacology education
To update and engage the pharmacology education community. To build the community. To create a space for sharing ideas and resources.




For the first time at the Society's flagship meeting, we will be welcoming late-breaking abstract submissions. To submit a late-breaking abstract please click the 'Abstract' button above.

Late breaking abstract submission deadline: Thursday 16 November 2017 (11:59 GMT)

A late-breaking abstract should

  • highlight latest high-impact science that will have an immediate and significant effect upon researchers and practitioners
  • comprise either result that were not yet known, or fully available, on the regular abstract submission deadline, 8 September 2017

The selection will be based on scientific quality and novelty of research either in basic, clinical science or education. Authors will be notified on the status of their submission on Thursday 23 November 2017. 

If you consider submit your late-breaking abstract, kindly note:

  • Be prepared to travel to the venue on short notice (only 2.5 weeks before Pharmacology 2017 starts) 
  • You will need to register online by 1 December 2017 close to the registration deadline, to benefit from complimentary (BPS members only) or reduced registration fees. 
  • Late-breaking abstracts will normally be accepted for poster presentation only.
  • The abstract titles and abstract body (where permission has been given) will be published in the conference app. 
  • No changes can be made to abstracts once they are finally submitted. You are welcome to bring an updated poster to the conference.

Please note that the late-breaking abstract deadline is not an extension of the general submission deadline.  

Late-breaking abstract submission guidelines
Abstract requirements for authors
Poster preparation guidelines
Sample abstract
Sample education abstract

Submission deadline: Friday 8 September 2017 (11:59PM GMT).

Please follow the abstract requirements, listed below, when submitting your abstract. If you have not followed the abstract requirements, please make the necessary changes prior to finalising your abstract submission.


Bursary submissions for Pharmacology 2017 are now closed. Authors will be informed on the outcome of their application w/c 23 October.

The British Pharmacological Society is making available bursary support for eligible members who are attending and presenting their work at the meeting, regardless of geography. Eligible members are generally expected to have been a member of the Society for at least one year and must have submitted an abstract and be presenting in the poster and/or oral sessions at the meeting. The maximum amount for individual bursaries and will usually be restricted to up to 75% of the aggregate cost of accommodation and travel for students and 50% for non-students. The maximum award is £750. Food and beverage costs and travel incidentals will not be reimbursed. Costs will be based on the Society’s assessment of the most economical mode of travel and a reasonable standard of accommodation

Care support bursaries
Care support bursaries are also available to members who have caring responsibilities and would benefit from financial support for caring costs. For further information, please click here

Submission deadline for care support bursary: Friday 17 November (11:59PM GMT).


MICE Concierge are the official concierge team for Pharmacology 2017, they are here to help take care of your booking requirements during your visit to London.
Using the official service means you get some great additional benefits:


How to book your accommodation

  • To book your delegate accommodation with MICE Concierge, please click here
  • Click on the ‘Official Core Hotels’ tab at the top of the page.
  • Scroll down to view the hotels available. Please note that the 'Park Plaza Westminster Bridge London' is the official event HQ hotel.
  • Click on 'Book Now' under the 'Official Flexible Event Rate'.
  • Select the number of rooms and click "next".
  • Enter your check in and check out dates, and your full name into the relevant fields. Please note the total cost of your stay will be displayed here.
  • Click on ‘Proceed to check-out’.
  • To finalise your booking and make payment you can either create an account with MICE Concierge or ‘Continue as Guest’.
  • Enter your payment details and select ‘next’ to finalise your accommodation.

Need help with registration?  

T: +44 (0) 1438 908770
Opening hours are Monday – Friday, 9.00am – 5.30pm (GMT), closed on weekends and Bank Holidays.


Queen Elizabeth II Conference Centre
Broad Sanctuary, Westminster
Tel: +44 (0)20 7222 5000


The nearest train stations are Charing Cross followed by a 12 minute walk and Victoria followed by a 14 minute walk.

The nearest tube stations are St. James's Park followed by a 4 minute walk and Westminster followed by a 6 minute walk.

The Q-Park Westminster car park is located just a short distance from the venue in Great College Street, SW1P 3RX.

Black cabs are readily available across the road from the QEII Conference Centre on Victoria Street. Should you wish to book a taxi, please call the Transport for London 24hr travel information centre on +44 (0)843 222 1234 or, between 09:00 and 18:00.

There are train and coach services from all London airports. Useful telephone numbers are:
Heathrow: +44 (0)844 335 1801
London City Airport: +44 (0)20 7646 0088
Gatwick: +44 (0)844 335 1802

Tourist information
London's primary Tourist Information Centre is: Victoria Station Travel Information Centre
Opposite platform 8, Victoria Railway Station, London, SW1V 1JU, Tube: Victoria
For further information about London and locations of other tourist information, please visit their website.

A wide range of sponsorship and exhibition opportunities are available at Pharmacology 2017.
For further information please contact Susanne Schweda at

Pharmacology 2017 supporters